Literature DB >> 28450718

Anticancer therapy: Re-educating macrophages.

M Teresa Villanueva.   

Abstract

Mesh:

Year:  2017        PMID: 28450718     DOI: 10.1038/nrd.2017.82

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.

Authors:  Jennifer L Guerriero; Alaba Sotayo; Holly E Ponichtera; Jessica A Castrillon; Alexandra L Pourzia; Sara Schad; Shawn F Johnson; Ruben D Carrasco; Suzan Lazo; Roderick T Bronson; Scott P Davis; Mercedes Lobera; Michael A Nolan; Anthony Letai
Journal:  Nature       Date:  2017-03-08       Impact factor: 49.962

2.  Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.

Authors:  Sharareh Gholamin; Siddhartha S Mitra; Abdullah H Feroze; Jie Liu; Suzana A Kahn; Michael Zhang; Rogelio Esparza; Chase Richard; Vijay Ramaswamy; Marc Remke; Anne K Volkmer; Stephen Willingham; Anitha Ponnuswami; Aaron McCarty; Patricia Lovelace; Theresa A Storm; Simone Schubert; Gregor Hutter; Cyndhavi Narayanan; Pauline Chu; Eric H Raabe; Griffith Harsh; Michael D Taylor; Michelle Monje; Yoon-Jae Cho; Ravi Majeti; Jens P Volkmer; Paul G Fisher; Gerald Grant; Gary K Steinberg; Hannes Vogel; Michael Edwards; Irving L Weissman; Samuel H Cheshier
Journal:  Sci Transl Med       Date:  2017-03-15       Impact factor: 17.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.